Retatrutide Where to Buy: $4.95/mg or $4.17/mg

Run these in sequence. The first three decide whether the vial holds what the label says. The next three separate a supplier holding stock from a reshipper who orders yours after you pay. The seventh is the one this site adds, and the only one that returns a comparable number.

A storefront that fails checks 1 to 3 is not a supplier you can price, because the milligram figure on its label is unverified. One that fails check 7 has quoted the price of a box, not the price of the compound.

A certificate of analysis is a report on one batch, produced on one date, by one laboratory. That is the whole of what it proves. The three checks exist to stop a generic PDF from standing in for a test of the material you were sent.

Batch specificity. The batch code on the certificate has to match the code printed on the vial you received. A certificate with no batch code, or a code that appears on every product a seller lists, describes nothing in particular.

A named external laboratory. The certificate should carry the name of a laboratory that does not belong to the seller. Ascension Peptides publishes two third-party certificates per batch of research retatrutide: one from Kovera Labs covering batches 03-05260628 and 43-05260628, tested 26 May 2026, and one from MZ Biolabs covering batches 03-01260229 and 43-01260229, tested 6 February 2026. Those are the vendor's published certificates, and they are checkable against the vial in front of you.

Two methods, not one. High-performance liquid chromatography measures how much of the sample is the target peak, which is purity. Mass spectrometry measures the molecular weight, which is identity. Purity without identity tells you a sample is 99% clean without saying what it is 99% clean of. Both belong on the certificate.

These three checks feed directly into the arithmetic further down. The milligram figure on a vial is an input to every calculation on this site, and a certificate is what makes that input worth using.

Stated strength. A listing that sells a vial without publishing its milligram content cannot be compared with anything. Retatrutide vials in this market are sold as 10 mg and 30 mg lyophilised powder, and those two numbers are the denominator in every price comparison you will run.

Stock location. Domestic stock is the difference between a package that dispatches the same day and one that clears an international border first. Ascension states same-day dispatch on orders placed before 2pm CST, Monday to Saturday, from US stock. A supplier with no dispatch cut-off published, or a multi-week processing window, is very likely ordering your vial after you pay for it.

Labelling and recourse. Research-use labelling is not a legal fig leaf you should resent, it is the condition under which the sale is lawful in the United States. A vendor that instead advertises human benefits has stepped outside that framing, and the FDA has been explicit about unapproved GLP-1 products marketed for weight loss. Read the refund terms before checkout, and check they cover the three failures that actually happen: wrong item, breakage in transit, and non-delivery.

Note what is absent. A supplier's own purity claim, a review count and a star rating are marketing outputs. Batch codes, laboratory names and dispatch cut-offs are checkable facts.

Vial price is the wrong unit. A 10 mg vial at $49.50 and a 30 mg vial at $125.00 look like a cheap option and an expensive option until you divide, at which point the expensive one turns out to be the cheaper compound.

The arithmetic is two divisions. $49.50 ÷ 10 mg = $4.95 per mg. $125.00 ÷ 30 mg = $4.1667 per mg, which rounds to $4.17. The gap is $0.78 per mg, which is about 16% of $4.95, so the 30 mg vial buys the same milligram for roughly a sixth less.

Bulk tiers do not overturn that. The published tiers take 3% off at three units, 5% at five and 10% at ten, calculated on the list price. Three R-30 vials at list is $750.00, less 3% is $727.50, for 90 mg, which works out at $8.08 per mg. Ten vials at $2,250.00 for 300 mg is $7.50 per mg. Both are well above the $4.17 the discount code produces on a single vial, so the code is the larger lever unless a checkout shows you otherwise. Our cheapest tirzepatide page makes the same point about a different compound: the headline number and the per-milligram number rarely rank the same way.

Here is the same checklist applied to the supplier this page recommends, with the evidence stated so you can disagree with it.

Two things this table deliberately does not claim. It does not state a purity percentage, because that figure belongs to the certificate for your batch rather than to a web page. And it does not price named rivals, because a quoted competitor price is wrong within a month.

The seven checks travel. The regulatory position does not. Retatrutide holds no MHRA authorisation, so a UK buyer is in the same position as a US buyer with respect to prescriptions, which is to say there is nothing to prescribe.

What differs is the shipment. A US-dispatched parcel entering the UK is an import, and imports of unapproved medicinal-classified material carry a real risk of seizure, along with VAT and a courier handling fee charged on delivery. Those charges land on the buyer, and they change the arithmetic: a $125.00 vial that attracts import VAT and a handling fee is no longer a $4.17 per mg vial by the time it reaches a UK address. Recalculate with the landed total, not the cart total.

UK-based storefronts advertising domestic retatrutide stock are usually reshipping the same US or Chinese material, with their own margin on top and, frequently, no batch-specific certificate at all. Run check 1 on them first, because it is the check they most often fail. Our UK buying guide works through the customs and VAT side in detail.

Nothing here is advice on moving a shipment through customs. The risk sits with the buyer, and this page cannot price it.

A checklist bounds your uncertainty, it does not remove it. Three limits are worth stating plainly.

• A certificate covers a batch, not your vial. Laboratories test a sample. Between the tested sample and the vial in your hand sit filling, capping, storage and transit, none of which the certificate observes.
• Labelled milligrams are not always peptide milligrams. Part of the mass in a lyophilised vial can be counterion and residual excipient. That matters for every calculation downstream, because the mg figure is the numerator in concentration and the denominator in cost per mg. Our peptide calculator guide covers why the arithmetic assumes a labelled figure it cannot itself verify.
• No supplier check changes the regulatory status. Retatrutide remains investigational. The Phase 2 results in the New England Journal of Medicine reported about 24% mean weight reduction at 48 weeks on the 12 mg arm, and the Phase 3 TRIUMPH programme is still running. A compound with strong trial data is still a compound with no approval, and material bought on this route is sold for laboratory research only.

Once a vial is on the bench, the arithmetic starts: reconstitution volume, mg/mL, units on the barrel. Our reconstitution guide and the reconstitution calculator handle that half.